Literature DB >> 14561596

Evaluation of head and neck squamous cell carcinoma after treatment.

Suresh K Mukherji, Gregory T Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14561596      PMCID： PMC7976320     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  28 in total

1.  Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.

Authors:  Y Anzai; W R Carroll; D J Quint; C R Bradford; S Minoshima; G T Wolf; R L Wahl
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

2.  Thallium-201 SPECT in the diagnosis of head and neck cancer.

Authors:  R A Valdés Olmos; A J Balm; F J Hilgers; W Koops; B M Loftus; I B Tan; S H Muller; C A Hoefnagel; R T Gregor
Journal:  J Nucl Med       Date:  1997-06       Impact factor: 10.057

3.  Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.

Authors:  P Li; H Zhuang; P D Mozley; A Denittis; D Yeh; M Machtay; R Smith; A Alavi
Journal:  Clin Nucl Med       Date:  2001-02       Impact factor: 7.794

4.  Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings.

Authors:  E Di Martino; B Nowak; H A Hassan; R Hausmann; G Adam; U Buell; M Westhofen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-12

5.  Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.

Authors:  S K Mukherji; M Gapany; D Phillips; B Neelon; S O'Brien; W McCartney; S Buejenovich; J S Parekh; J P Noordzij; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

6.  Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.

Authors:  N J Fischbein; O S AAssar; G R Caputo; M J Kaplan; M I Singer; D C Price; W P Dillon; R A Hawkins
Journal:  AJNR Am J Neuroradiol       Date:  1998-08       Impact factor: 3.825

7.  Radiologic appearance of the irradiated larynx. Part II. Primary site response.

Authors:  S K Mukherji; A A Mancuso; I M Kotzur; W M Mendenhall; P S Kubilis; R P Tart; D Freeman; W R Lee
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

8.  18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.

Authors:  P Paulus; A Sambon; D Vivegnis; R Hustinx; P Moreau; J Collignon; J M Deneufbourg; P Rigo
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

9.  CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction.

Authors:  P A Hudgins; J G Burson; G S Gussack; W J Grist
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

Review 10.  Preliminary experience with thallous chloride T1 201-labeled single-photon emission computed tomography scanning in head and neck cancer.

Authors:  R T Gregor; R Valdés-Olmos; W Koops; A J Balm; F J Hilgers; C A Hoefnagel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-05
View more
  13 in total

1.  US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions.

Authors:  Lorenzo Preda; Elvio De Fiori; Cristiano Rampinelli; Mohssen Ansarin; Giuseppe Petralia; Fausto Maffini; Daniela Alterio; Luke Bonello; Fausto Chiesa; Massimo Bellomi
Journal:  Eur Radiol       Date:  2009-12-17       Impact factor: 5.315

2.  MRI and PET-CT: Comparison in post-treatment evaluation of head and neck squamous cell carcinomas.

Authors:  Hari Mukundan; Arti Sarin; B S Gill; Anand Neelakantan
Journal:  Med J Armed Forces India       Date:  2014-03-12

Review 3.  Postoperative Imaging and Surveillance in Large Nerve Perineural Spread.

Authors:  Jennifer Sommerville; Mitesh Gandhi
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-09

Review 4.  Assessment of treatment response after chemoradiation of head and neck cancer.

Authors:  Fernando Luiz Dias
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

5.  Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer.

Authors:  P T Figueiredo; A F Leite; A C Freitas; L A Nascimento; M G Cavalcanti; N S Melo; E N Guerra
Journal:  Dentomaxillofac Radiol       Date:  2010-03       Impact factor: 2.419

6.  Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI.

Authors:  J Y Lee; K L Cheng; J H Lee; Y J Choi; H W Kim; Y S Sung; S R Chung; K H Ryu; M S Chung; S Y Kim; S-W Lee; J H Baek
Journal:  AJNR Am J Neuroradiol       Date:  2019-07-18       Impact factor: 3.825

7.  Multiplanar functional imaging of the larynx and hypopharynx with multislice spiral CT.

Authors:  Michael M Lell; Holger Greess; Torsten Hothorn; Rolf Janka; Werner A Bautz; Ulrich Baum
Journal:  Eur Radiol       Date:  2004-10-08       Impact factor: 5.315

8.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

9.  Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.

Authors:  Redina Ljumanovic; Johannes A Langendijk; Otto S Hoekstra; Dirk L Knol; C René Leemans; Jonas A Castelijns
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

10.  Post-treatment imaging of head and neck cancer.

Authors:  R Hermans
Journal:  Cancer Imaging       Date:  2004-02-12       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.